Ellanse

For healthcare professionals. This article is intended for verified healthcare professionals and aesthetic clinic teams. Ellanse is a dual-action dermal filler based on poly-e-caprolactone (PCL). It provides immediate volumisation through its carrier gel and longer-lasting results through collagen stimulation, giving practitioners a single product that addresses both the immediate and the gradual elements of facial correction. Ellanse is CE 0344 marked and approved in at least 70 countries worldwide. It is indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial ageing signs or conditions, and has been shown to be an effective and safe treatment for volumisation and skin rejuvenation. Ellanse sits within the biostimulatory injectable category and is available to verified healthcare professionals through Healthxchange across the UK and Ireland. Explore the range below.